Case #1 - UNC School of Medicine
Download
Report
Transcript Case #1 - UNC School of Medicine
Case #1
Alexa Simon MSIV
September 19, 2007
UNC Infectious Disease
CC: Nausea vomiting, fever
HPI: 56 y/0 AAF with history significant for
ovarian cancer stage IIIC with a complicated
surgical history including debulking surgery in
2005, ileocecal resection, and recent repair of
enterocutaneous fistula presented to Johnston
Memorial with acute onset of nausea, vomiting,
fever and abdominal pain.
HPI cont….
At JM she was found on CT scan to have fluid
collection in the anterior subcutaneous tissue.
She was started on Zosyn
Patient was transferred to Gyn/Onc at UNC and
started on Ceftazidine and Flagyl.
HPI cont….
She progressively became more hypotension with
increasing 02 requirements:
Became obtunded and ID consult team was paged.
The Ob/gyn resident ended phone call to ID saying “I need to
go intubate the patient.”
Tumor History
Prior to 2005 was healthy
9/2005: Presents with abdominal pain
CT with massive ascites and 2 large adnexal masses
CA-125>300
9/29/2005: Ex-laporatomy BSO with iliocecal resection,
Re-anastomosis omentectomy
Suboptimal debulking mass
PE with attempted VIR for embolectomy of saddle
embolus
Multiple MIs
TPN dependence begins
12/2005: Chemotherapy began with Taxol
7/2007: Repair enterocutaneous fistula
Infection History
10/2006: Candida albicans and coagulase negative staphylococcal
infection at port site
Rx: Fluconazole and daptomycin for 2 wks
11/2006: Candida parapsilosis fungemia
Rx: Capsofungin with 8 wks
1/2007: Coagulase negative staphylococcal and ampicillin
sensitive enterococcal bacteremia
Rx: Daptomycin
3/07: Coagulase negative staphylococcal bacteremia
Rx: Daptomycin
7/2007 coag negative staph line infection and UTIs with
enterococci and candida
Rx: Linezolid and fluconazole
Additional History
SH:
Patient denies alcohol, tobacco, drugs
Family History
Mother had ovarian cancer
Father had prostate cancer
ROS: unobtainable due to intubation and sedation
Additional History
Meds
Ceftazidine 2g IV q12
Flagyl 500mg q12
Linezolid 600mg q12
Micafungin 100 mg IV QD
Dopamine GGT
Morphine PRN
Benadryl PRN
Phenergan PRN
Zofran PRN
Allergies
Zosyn: Rash
Ace Inhibitors: Rash
Vancomycin: Rash
PCN: Rash
Zofran: Rash
Physical Exam
Vitals: Tmax 36.8/Tc: 35.9 BP:110/58 P:87 CVP:14-17
Vent: SIMV PS:10 PEEP:5 FIO2%:40 TV 600 Rate 16
General: Intubated, withdraws from pain 6-7/T
HEENT: Icteric, PERRLA, no LAD
CV: RRR 2/6 holosystolic murmur, non radiating on left sternal
border; no rubs or gallops
Lungs: Crackles Bilaterally at bases
Skin: jaundiced, no rash or bruising noted
Abdomen: tender throughout, no rebound, hypoactive bowel
sounds; multiple surgical scars, with palpable subcutaneous
midline mass (not fluctuant)
No hepatosplenomegaly appreciated
Extremities: 1+ pitting edema bilaterally
Labs:
9.2
20.7
51
27.5
Ca:7.4
Mg:1.9
GGT:122
Differential:
ANC: 18.0↑
ALC:0.8
AMC: 0.8
AEC:0.2
ABC: 0
139 112
31
71
3.1 14
Phos:4.6
1.5
6.2
2.2
21.6
20.4
84
74
181
Radiology
RUQ US:
Lack visualized flow in portal veins/SMV, some
echogenic material in portal veins concerning
for clot
Hepatomegaly
New extrahepatic biliary ductal dilations
CT Adomen/ Pelvis
Radiology
CTA Abdomen:
Fluid collections contain focal area of gas with density
within the soft tissues overlaying a anterior abdominal
wall may represent abscess
Increase in the size of multiple high density lesions seen
in the liver, which contain calcifications.
Low density fluid in pelvis collection with in abdomen
c/w ascites
Stable Left pleural effusion
DISCUSSION………..
Her Results:
Microbiology:
Urine Culture: gram positive
cocci in chains
Blood Culture (peripheral and
central line):
GPCs in chains and GPRs
Abdominal abscess: GPCs in
chains
TTE:
Left Ventricle: hyperdynamic EF: 6570%
Mitral Valve: thickened with mild
prolapse, moderate regurgitation
Aortic Valve: trileaflet with mild
thickening
Right Ventricle: normal
Tricupsid Valve: mild thickening
with mobile echo from the atrial
surface consistent with
degenerative, disease and
vegetation, with mild regurgitation
Pulmonary Valve: not well imagine
Infectious Disease Diagnosis
Bacteremia:
Enterococci (ampicillin sensitive, but gentamicin R)
Bacillus cereus
Endocarditis of the tricuspid valve
Antibiotics used: Imepenem/cilastin and daptomycin
used to treat for 12 weeks
B. cereus now…
Bacillus cereus
Commonly found in soil, inanimate objects, and
mucus membranes healthy people
Gram positive motile rods with paracentral spores
Taxonomy of 3 groups: large cell subgroup, small cell,
mixed
Large group is B. anthracis and cereus
They differ by fewer 9 nucleotides
Bacillus cereus cont’d…
Grows on blood agar as large flat, granular, ground glass,
beta-hemolytic
Grows aerobically and a facultative anaerobe
Contains catalase, hemolysins, beta-lactamases, oxididase
Ferments glucose, maltose, sucrose, trehalose
Does not ferment lactose, xylose, mannitol
Resistant to heat
Motile
Bacillus cereus Toxins
Enterotoxin- can be necrotizing
Emetic toxin- mitochondrial toxin
Inhibits mitochondrial fatty-acid oxidation
Can cause liver failure
Phospholipases- release lysozyme enzymes (like alpha
toxin c. perfringens)
Proteases
Hemolysins-causing cell lysis of leukocytes and
macrophages
Beta-lactamases thus resistant to most PCNs
Bacillus cereus Infections
1: Local (burns, trauma, post op, fulminant eye infections)
2: Bacteremia/septicemia
3: CNS
4: Respiratory infection
5: Endocarditis, pericarditis
6: Food poisoning, toxin induced
Increase in non-food poisoning in IVDU, neonates,
malignancy, AIDs, prosthetic parts
Most common form is GI intoxication from spores by
enterotoxins
Food-Poisoning
Occurs 6-8hrs after ingesting B. cereus
toxins
Patients typically have significant emesis
and less frequently diarrhea
Enterotoxins : hemolysin, non-hemolytic
enterotoxin, enterotoxin T, and cytotoxin K
Emetic toxin
No fevers because not systemic disease
Commonly isolated from reheated foods
Endophthalmitis
5/10,000 hospital patients
60% occur after intraocular surgery
Often due to transient bacterial contamination by conjuctival flora
4-13% after penetrating trauma
Once inoculated bacillus spreads through out whole eye
If motile strain <12 hours to detect inflammatory reaction in the eye
Symptoms: pain “ache”, redness, blurry vision, ring corneal infiltrate
Loss retinal function in 18hours if fully virulent (pclR gene and motile)
High morbidity with loss of vision in infected eye
Phospholipases toxins responsible for the destructions
Treatment is injection of antibiotics into the vitreous and vitrectomy, along
with systemic antibiotics.
5 year Review of Cleveland Hospitals
From: 1981-1986
38 patients with significant Bacillus infections:
78.9% bacteremia
1/3 IVDU or had indwelling catheters, 4 had cancer
30% IVDU
7.9% endopthalmitis
1.8% Endocarditis (only with IVDU)
Osteomyelitis
Visceral infection- significant morbidity
1 pneumonia and1 necrotizing fasciitis after trauma
Medicine (Baltimore) 1987;66(3):218-23.
5 year Review continued…
Intravascular device (pacemaker, central line) is a
cause of the nosocomial bacillus bacteremia
4/38 patients improved after removal intravascular
catheter with out antibiotics
Endocarditis rare phenomenon with B. Cereus
Overall patients with primary bacteremia
recovered quicker and had less morbidity then
patient with a localized infection
Medicine (Baltimore) 1987;66(3):218-23.
Bacillus spp. Among hospitalized patients
with Haematological malignancies
3.4% bacteremic with bacillus spp.
Most only presented with fever
Few cases of pneumonia, GI/Hepatic symptoms
Patients that are granulocytopenic are at risk for
opportunistic infections with bacillus
Many species can effect neutropenic patients which in
clude B. licheniformis, B. cereus, B. pumilus
All patient were bacteremic, only few had
pneumonias, endocarditis, or localized infections
Journal of Hospital Infections 2006.;64(2):169-76.
Pseudo Epidemics
Outbreaks have been seen in dialysis units, ICUs, neonatal
ICUs
Bacillus spores are sticky
Non-sterile cotton wool
Laundered linens including gowns, sheets
Ventilation systems
Dressings
Hands
Dairy plants- filling machines
Korean dried red pepper
Contaminated Transfusions
Platelet transfusions: contaminated 0.08-0.7 %
Stored at room temperatures, thus longer storage time
increase risk of contamination
Possible contaminants: dipthroid rods, coagulase negative
staph, B. cereus, E. cloacae, E. coli, P. aeruginosa
Most cases deteriorated with minutes of transfusion
Leading to hospital outbreaks of infections
More common with patients with hematological malignancy
Second to transfusions or long term indwelling catheters
Blood transfusions no data seen
Treatment
B. Cereus inherently resistant to most beta-lactams
Antibiotics known to work:
Imipenem
Clindamycin
In vitro activities of antibiotics on Bacillus spp and Spores
Aminoglycosides: MIC 2-0.5
Doxycycline: MIC 0.5
Vancomycin: MIC 1
Erythromycin: MIC>16
Ciprofloxacin: MIC 0.25
Daptomycin: MIC 1
Journal of Clinical Microbiology 2006;44(10):3814-18
References
te Boekhorst PA, et al. Clinical significance of bacteriologic screening in platelet
concentrates. Transfusion 2005;45(4):514-19.
Drobniewski FA. Bacillus cereus and related species. Clinical microbiology
reviews 1993;6(4):324-38.
Sliman R, et al. Serious infections caused by bacillus species. Medicine
(Baltimore)1987;66(3):218-23.
Rotman B, Cote MA. Application of real-time biosensor to detect bacteria in
platelet concentrates. Biochemical and biophysical research communications
2003;300(1):197-200.
Yomtovian R, et al. A prospective microbiologic surveillance program to detect
and prevent the transfusion of bacterial contaminated platelets. Transfusion
1993;33(11):902-9.
Guinebretiere MK, et al. Enterotoxigenic profiles of food-poisoning and foodborne bacillus cereus strains. Journal of Clinical Microbiology 2002;40(8):305356.
References (cont’d.)
Callegan M, et al. Bacillus endophthalmitis: Role of bacterial toxins and
motility during infections. Investigative Ophthalmology and Visual Science
2005;46(9):3233-8.
Citron DM, Appleman MD. In vitro activities of daptomycin, ciprofloxacin, and
other antimicrobial agents against the cells and spores of clinical isolates of
bacillus species. Journal of Clinical Microbiology 2006;44(10):3814-8.
Mahler H, et al. Fulminant liver failure in association with the emetic toxin of
bacillus cereus. NEJM 1997;336(16):1142-8.
Ozkocaman V, et al. Bacillus spp. among hospitalized patients with
haematological malignancies: clinical features, epidemics and outcomes.
Journal of Hospital Infections 2006;64(2):169-76.
Search PubMed
Bacillus Cereus Bacteremia
Case Reports
Reviews
Differential Diagnosis
Drug Therapy